A detailed history of Lokken Investment Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Lokken Investment Group LLC holds 9,698 shares of ABT stock, worth $1.11 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
9,698
Previous 8,815 10.02%
Holding current value
$1.11 Million
Previous $915,000 20.77%
% of portfolio
0.49%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $88,361 - $104,308
883 Added 10.02%
9,698 $1.11 Million
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $887,934 - $991,158
8,815 New
8,815 $915,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lokken Investment Group LLC Portfolio

Follow Lokken Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lokken Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lokken Investment Group LLC with notifications on news.